{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-009086","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.746535+00:00","generated_at":"2026-06-06T13:32:22.822523+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Corbus suspends ATM equity offering program, terminates Jan 29 prospectus supplement","bullets":["Suspended and terminated the ATM prospectus supplement dated Jan 29, 2024, under Sale Agreement with Jefferies.","No sales of common stock until a new prospectus supplement is filed.","The underlying Sale Agreement dated August 6, 2020, remains in full force and effect."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-009086","json":"https://secwatch.observer/filing/0000950170-24-009086.json","markdown":"https://secwatch.observer/filing/0000950170-24-009086.md","text":"https://secwatch.observer/filing/0000950170-24-009086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024009086/0000950170-24-009086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024009086/crbp-20240130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T13:32:22.822523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}